Abstracts

BICTEGRAVIR/FTC/TAF SINGLE-TABLET-REGIMEN IN ADOLESCENTS: WEEK 24 RESULTS

Bictegravir (BIC), a novel, unboosted integrase strand transfer inhibitor (INSTI) with a high genetic barrier to resistance, has been coformulated with emtricitabine and tenofovir alafenamide (BIC/FTC/TAF; B/F/TAF) into a once daily, single-tablet regimen (STR) of small tablet size that can be taken with/without food. We report pharmacokinetics (PK), safety and efficacy from a planned interim…

P1101: PHASEI/II STUDY OF RALTEGRAVIR CONTAINING REGIMEN IN HIV-TB COTREATED CHILDREN

Current antiretroviral (ARV) treatment options for children co-infected with TB and HIV-infection are limited. RIF induces UDP-glucuronosyltransferase activity accelerating the clearance of raltegravir (RAL). In adults, doubling the RAL dose partially overcame this PK interaction with no safety concerns. We sought to determine the optimal and safe dose of RAL when administered with RIF-containing anti-TB…

MILESTONES AND OUTCOMES OF YOUNG ADULTS WITH PERINATAL HIV INFECTION OR EXPOSURE

With aging of the population with perinatal HIV infection (PHIV+) in the US, concerns have emerged about transition into adulthood. Using data from CASAH, one of the largest behavioral longitudinal cohort studies on PHIV+ and perinatally HIV-exposed uninfected (PHEU) youth, we examined young adult (YA) milestones, and behavioral and biomedical outcomes. Participants were recruited from…

VIRUS-LIKE NANOCARRIER FOR DELIVERY OF BIOMOLECULES BETWEEN CELLS

Targeted delivery of biomolecules such as proteins, mRNAs, and DNA editing complexes is one of the biggest challenges in realizing the promise of treating many diseases. Emerging research is demonstrating the potential of engineering viral capsids directly as vehicles and/or as inspirations for designing new nanocarrier delivery systems. This approach is attractive because viral capsid…

3D AND MULTI-SCALE IMAGING OF HIV-1 SPREAD IN TISSUES

Critical aspects of HIV-1 infection occur in mucosal tissues, which contain large numbers of HIV-1 target cells that are depleted early in infection. We used electron tomography (ET) to image HIV-1 in tissues of HIV-1–infected humanized mice. The resolution and preservation quality of reconstructed tissue volumes allowed identification of budding virions and free virions in…

SINGLE CELL VIRAL AND RECEPTOR BAR CODES: BEYOND THE SINGLE CELL TRANSCRIPTOME

By simultaneously determining millions or billions of individual nucleic acid sequences in a single experiment, next-generation sequencing technologies allow the analysis of rare events even in the context of very large populations. Therefore, these technologies can help facilitate study of HIV genetic variants or HIV-infected cells within highly heterogeneous ex vivo samples from HIV-positive individuals.…

MEASURING THE POPULATION-LEVEL IMPACT OF INTERVENTIONS

Population-based assessments of treatment and prevention efforts, whether in the setting of research studies or routine service delivery, are an increasingly important tool to evaluate the impact of interventions and inform future action. This talk will provide an overview of methods for measuring the population-level impact of interventions, including serial population cohorts, community-cluster randomized controlled…

PRAGMATIC TRIALS

Pragmatic trials aim to evaluate how an intervention will perform in real-world conditions, contrasting with explanatory trials, which aim to determine whether an intervention can work under experimental conditions. The extent to which a trial is pragmatic can be assessed across multiple domains, including whether the study population is highly selected or has broader inclusion…